Skip to main content
Explore URMC

Nabeel Badri, M.B.Ch.B.

Contact Information

Phone Numbers

Appointment: (585) 276-3000

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting



I am a medical oncologist at the Wilmot Cancer Institute, University of Rochester Medical Center. I am specialized in treating gastroenterology malignancies. My primary research interest has focused on gastrointestinal malignancies. Currently, I have been involved in various studies/clinical-trials investigating novel approaches and chemo-therapeutics to treat gastrointestinal cancer.

Conditions I treat:

* Esophageal cancer
* Stomach cancer
* Pancreatic cancer
* Colon cancer
* Rectal cancer
* Anal cancer
* Neuroendocrine tumors and carcinoid tumors
* Liver cancer: Hepatocellular carcinoma (HCC)
* Bile duct cancer
* Cholangiocarcinoma
* Appendiceal cancer and tumors



MBBCH | Al-Kindy College of Medicine (Iraq)

Post-doctoral Training & Residency

07/01/2018 - 06/30/2020
Fellowship in Hematology & Oncology at University of Rochester Medical Center

07/01/2017 - 06/30/2018
Fellowship in Hematology & Oncology at Howard University Hospital

07/01/2015 - 06/30/2017
Residency in Internal Medicine at Texas Tech University Health Sciences Center-EP

07/01/2014 - 06/30/2015
Internship in Internal Medicine at Texas Tech University Health Sciences Center-EP

VIEW ALL expand_more


Journal Articles

Nahleh Z, Otoukesh S, Mirshahidi HR, Nguyen AL, Nagaraj G, Botrus G, Badri N, Diab N, Alvarado A, Sanchez LA, Dwivedi AK. "Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics." Cancer medicine. 2018 Jun; 7(6):2710-2717. Epub 2018 May 07.

Elzamly S, Badri N, Padilla O, Dwivedi AK, Alvarado LA, Hamilton M, Diab N, Rock C, Elfar A, Teleb M, Sanchez L, Nahleh Z. "Epithelial-Mesenchymal Transition Markers in Breast Cancer and Pathological Responseafter Neoadjuvant Chemotherapy." Breast cancer : basic and clinical research.. 2018 12:1178223418788074. Epub 2018 Aug 01.

Montoya A, Amaya CN, Belmont A, Diab N, Trevino R, Villanueva G, Rains S, Sanchez LA, Badri N, Otoukesh S, Khammanivong A, Liss D, Baca ST, Aguilera RJ, Dickerson EB, Torabi A, Dwivedi AK, Abbas A, Chambers K, Bryan BA, Nahleh Z. "Use of non-selective ?-blockers is associated with decreased tumor proliferative indices in early stage breast cancer." Oncotarget.. 2017 Jan 24; 8(4):6446-6460.